TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME

This adverse event was reported 247 times

TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PREDNISOLONE ACETATE 7 0.0006
1 CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE 1 0.0005
2 LAMOTIRIGINE 31 0.0004
3 LAMOTRIGINE CHEWABLE DISPERSIBLE 31 0.0004
4 KETOROLAC TROMETHAMINE 2 0.0004
5 AMPICILLIN SODIUM AND SULBACTAM SODIUM 1 0.0004
6 CLINDAMYCIN PHOSPHATE 2 0.0004
7 AZILSARTAN KAMEDOXOMIL 1 0.0003
8 CEFIXIME 1 0.0003
9 ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE 2 0.0003
See all drugs enriched for association with TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME

TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Nucleoside Analog Antifungal [EPC] 1 0.0007
1 Sulfonamide Antibacterial [EPC] 1 0.0003
2 Antiparasitic [EPC] 1 0.0002
3 Pediculicide [EPC] 1 0.0002
4 Provitamin D2 Compound [EPC] 6 0.0002
5 Catechol-O-Methyltransferase Inhibitor [EPC] 1 0.0002
6 Bismuth [EPC] 1 0.0002
7 Anti-epileptic Agent [EPC] 32 0.0001
8 Mood Stabilizer [EPC] 31 0.0001
9 Allylamine Antifungal [EPC] 1 0.0001
See all drug classes enriched for association with TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME